Malignant Musculoskeletal Neoplasm — Trials

Malignant Musculoskeletal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

465 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 141
Recruiting: 73
Ph III recruiting: 6
Growth YoY: −28%
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 30.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (58)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05691478	A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma	suspended	Phase 2 / Phase 3	1,122	National Cancer Institute (NCI)NIH	4	Sep 29, 2026	clinicaltrials
NCT04890093	Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors	suspended	Phase 1 / Phase 2	64	National Cancer Institute (NCI)NIH	1	Mar 16, 2026